Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selection
(NASDAQ: ADTX) Delayed: 0.04 +0.02 (100.00%)
Previous Close $0.02    52 Week High $ 
Open $0.02    52 Week Low $ 
Day High $0.06    P/E N/A 
Day Low $0.02    EPS $ 
Volume 2,147,483,647